Kuangli Bio-Tech Holdings Co (TPE:6431) Change In Payables And Accrued Expense : NT$0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Kuangli Bio-Tech Holdings Co Change In Payables And Accrued Expense?

Kuangli Bio-Tech Holdings Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was NT$0.0 Mil. It means Kuangli Bio-Tech Holdings Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Kuangli Bio-Tech Holdings Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was NT$0.0 Mil. It means Kuangli Bio-Tech Holdings Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Kuangli Bio-Tech Holdings Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Kuangli Bio-Tech Holdings Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuangli Bio-Tech Holdings Co Change In Payables And Accrued Expense Chart

Kuangli Bio-Tech Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Kuangli Bio-Tech Holdings Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Kuangli Bio-Tech Holdings Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

Kuangli Bio-Tech Holdings Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Kuangli Bio-Tech Holdings Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuangli Bio-Tech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Kuangli Bio-Tech Holdings Co Ltd (TPE:6431) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jianguo North Road, 9th Floor, No. 66, Section. 2, Zhongshan District, Taipei, TWN, 10485

Website

https://www.kl-holdings.com

Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.

Kuangli Bio-Tech Holdings Co Headlines

No Headlines